Delivery Order SPE2DB20D7059-SPE2DB25FQKN1
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,174.18 on August 13, 2025, for the supply of Dobutamine 500 mg/250 mL in D5W solution (250 mL units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,282.48 to AmerisourceBergen Drug Corp for Dobutamine 500 mg/250 mL in D5W solution (250 mL). This contract represents a firm fixed-price delivery order with no set-aside designation, competitively awarded on July 14, 2025, with an ultimate completion date of July 15, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,257.50 to AmerisourceBergen Drug Corp for the supply of Dobutamine 500 mg/250 mL in D5W solution (250 mL). This contract was competitively awarded with no set-aside designation under a firm fixed-price arrangement, with an ultimate completion date of August 15, 2025. AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, will serve as the point of performance for this pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $4,658.91 to AmerisourceBergen Drug Corp for the supply of Dobutamine 500 mg/250 mL in D5W solution (250 mL units). This competitive award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, utilizes a firm fixed price contract type with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Dobutamine 500 mg/250 mL in D5W solution. This delivery order, valued at $1,158.36 with a firm fixed price structure, represents a competitively awarded, non-set-aside procurement designed to support federal medical supply requirements. The contract is scheduled for ultimate completion on May 5, 2025, with performance taking place at AmerisourceBergen's...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Dobutamine 500 mg/250 mL in D5W solution (250 mL units). This firm fixed-price delivery order, valued at $1,686.34, represents a non-competitive set-aside order and is scheduled for completion by August 14, 2025. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dobutamine 500 mg/250 mL in 5% dextrose solution with a ceiling value of $1,748.21. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Dobutamine 500 mg/250 mL in D5W solution (250 mL units). This non-set-aside, competitively awarded contract is valued at $2,881.19 with a firm fixed price structure and an ultimate completion date of July 31, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Dobutamine 500 mg/250 ml in D5W solution. This firm fixed-price delivery order, valued at $2,139.28, is scheduled for completion by August 13, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award was made on a competitive basis with no set-aside designation, reflecting the contractor's established capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2024, for the supply of Dobutamine 500 mg/250 mL in D5W solution, with a contract value of $1,239.62 and ultimate completion date of November 5, 2024. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQKN1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,269.04 to AmerisourceBergen Drug Corp for Dobutamine 500 mg/250 mL in D5W 250 mL on June 25, 2025, with an ultimate completion date of June 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract involves the supply of a critical cardiovascular medication used in military and federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, encompassing a broad range of pharmaceutical products, specialty medications, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen's track record of competitively awarded federal contracts demonstrates its capability to meet diverse and time-sensitive medical procurement requirements across the federal healthcare network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 6/25/25 |